Industries > Pharma > Antibacterial Drugs Market Report 2020-2030
Antibacterial Drugs Market Report 2020-2030
Forecasts by Type (Cephalosporins (Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam, Others), Penicillins (Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic Amoxicllin-clavulanic Acid, Amoxil, Others), Fluoroquinolones (Avelox, Cravit, Vigamox, Ciprodex, Cipro/Cirpobay, Geninax, Baxdela, Others), Macrolides (Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin, Others), by Carbapenems (Invanz, Merrem/Meropen, Primaxin, Doribax, Others), Others (Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin)), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-Commerce), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Analysis of Leading Drug Discovery Outsourcing Companies. PLUS, COVID-19 Recovery Scenarios
Antibacterial Drugs– our new study reveals trends, R&D progress, and predicted revenues
Where is the Antibacterial Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 391 page report provides 231 Tables and 285 Figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market drivers, restraints/challenges, opportunities, PEST, SWOT, and Porter’s Fiver Forces Analysis), company profiles (financials 2015 to 2020, products, recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and submarkets
Global Antibacterial Drugs Market Segmentation
By Type
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others
By Cephalosporins
• Rocephin
• Sulperazon
• Ceftin/Zinnat
• Meiact
• Flomox
• Teflaro
• Zeftera
• Ceftolozane-tazobactam
• Ceftazidime-Avibactam
By Penicillins
• Generic Amoxicillin
• Augmentin
• Zosyn/Tazocin
• Unasyn
• Generic amoxicllin-clavulanic acid
• Amoxil
• Others
By Fluoroquinolones
• Avelox
• Cravit
• Vigamox
• Ciprodex
• Cipro/Cirpobay
• Geninax
• Baxdela
• Others
By Macrolides
• Biaxin/Clarith
• Zithromax
• Dalacin
• Dificid
• Solithromycin
• Others
By Carbapenems
• Invanz
• Merrem/Meropen
• Primaxin
• Doribax
• Others
By Other Sectors
• Zyvox
• Cubicin
• Tygacil
• TOBI/TIP
• Solodyn
• Vibativ
• Sirturo
• Tedizolid
• Oritavancin
• Dalbavancin
• Nemonoxacin
• Surotomycin
• Others
By Distribution Channel
• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
Middle East and Africa
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading 15 companies in the Antibacterial Drugs Market, with a focus on this segment of these companies’ operations.
Leading 15 companies and the potential for market growth
Overall world revenue for Antibacterial Drugs Market will surpass US$xx million in 2020, our work calculates. We predict a growth rate of over xx% from 2020 to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Antibacterial Drugs Market report helps you
In summary, our 391 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for Antibacterial Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 18 key national markets – See forecasts for the Antibacterial Drugs market in North America, Europe, Asia-Pacific, Latin America and MEA. Also, the report provides forecasts for all the major economies such as U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, GCC, and South Africa
• Prospects for established firms and those seeking to enter the market– including company profiles for Pfizer Inc., Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, BioVersys AG, Allecra Therapeutics GmbH, Adenium Biotech ApS, Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Inc., AstraZeneca PLC, Allergan, Melinta Therapeutics, SHIONOGI Co., Ltd., and DAIICHI SANKYO COMPANY, LIMITED involved in the Antibacterial Drugs Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Antibacterial Drugs Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our Global Antibacterial Drugs Market Analysis. today and Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Introduction to Antibacterial Drugs Market
1.2 Global Antibacterial Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1. COVID-19 Impact: Recovery Scenarios
1.7.2. Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Global Antibacterial Drugs Market Overview
3.1 Market Trend Analysis
3.1.1. Drivers
3.1.1.1. Rise in Bacterial Infections
3.1.1.2. Growth Strategies Adopted by Market Players
3.1.2. Restraints
3.1.2.1. Economic Barriers of Antibiotic R&D
3.1.2.2. Misuse of Antibiotics and Resistance Crisis
3.1.2.3. Generic Erosion and Prescription Control Will Limit Market Growth
3.1.2.4. Other Factor Challenging Market Growth
3.1.2.5. Resistance to Commonly Prescribed Antibacterial
3.1.3. Opportunities
3.1.3.1. Growing Demand From Emerging Economies
3.1.3.2. Introduction of new approaches for managing bacterial infections
3.2 SWOT Analysis
3.2.1. Strengths
3.2.2. Weaknesses
3.2.3. Opportunities
3.2.4. Threats
3.3 Porter’s Five Forces
3.3.1. Low Buyer Power
3.3.2. Low Supplier Power
3.3.3. Highly Competitive Rivalry
3.3.4. Low Threat of Substitute
3.3.5. Moderate Threat of New Entrants
3.4 Industry analysis – PEST Analysis
3.4.1. Political
3.4.1.1. Regulatory requirements must be simplified and harmonized globally
3.4.1.2. Government bodies are investing heavily in antibiotic development
3.4.1.3. Governments and regulatory agencies are incentivizing antibiotic development
3.4.2. Economical
3.4.2.1. Big pharma companies have decreased investment in this sector, but there are many small biotech with innovative products
3.4.2.2. Generic use is widespread in the antibacterial drugs industry
3.4.2.3. Potential returns on investment need to increase
3.4.3. Social
3.4.3.1. Bacterial infections represent a major disease burden
3.4.3.2. Increasing incidence of serious diseases
3.4.3.3. Frequent multinational travel is helping to spread drug-resistant strains rapidly
3.4.4. Technological
3.4.4.1. Improved diagnostics will allow for better selection of the appropriate therapy
3.4.4.2. Novel biologics such as bacteriophages are in early stages of development
3.4.4.3. New technologies will improve HAI prevention
3.5 Value Chain Analysis
4 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Type
4.1 Cephalosporins: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.1.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.1.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.1.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.1.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.2 Penicillins Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.2.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.2.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.2.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.2.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.3 Fluoroquinolones Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.3.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.3.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.3.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.3.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.4 Macrolides Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.4.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.4.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.4.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.4.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.5 4.5 Carbapenems Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.5.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.5.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.5.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.5.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.6 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.6.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.6.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.6.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
4.6.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Cephalosporins
5.1 Rocephin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.2 Sulperazon Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.3 Ceftin/Zinnat Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.4 Meiact Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.5 Flomox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.6 Teflaro Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.7 Zeftera Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.8 Ceftolozane-tazobactam Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.9 Zavicefta (CAZ-AVI) (Ceftazidime-Avibactam) Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
5.10 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Penicillins
6.1 Generic Amoxicillin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.2 Augmentin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.3 Zosyn/Tazocin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.4 Unasyn Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.5 Generic amoxicllin-clavulanic acid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.6 Amoxil Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
6.7 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Fluoroquinolones
7.1 Avelox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2 Cravit/Levaquin (levofloxacin) Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.3 Vigamox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.4 Ciprodex Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.5 Cipro/Cirpobay Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.6 Geninax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.7 Baxdela Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.8 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Macrolides
8.1 Biaxin/Clarith Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2 Zithromax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3 Dalacin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.4 Dificid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.5 Solithromycin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.6 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Carbapenems
9.1 Invanz Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.2 Merrem/Meropen Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.3 Primaxin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.4 Doribax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.5 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Other Sectors
10.1 Zyvox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.2 Cubicin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.3 Tygacil Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.4 TOBI/TIP Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.5 Solodyn Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.6 Vibativ Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.7 Sirturo Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.8 Tedizolid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.9 Oritavancin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.10 Dalbavancin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.11 Nemonoxacin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.12 Surotomycin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10.13 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Distribution Channel
11.1 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.1.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.1.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.1.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.1.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.2 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.2.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.2.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.2.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.2.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.3 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.3.1. “V” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.3.2. “U” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.3.3. “W” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
11.3.4. “L” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
12 Regional and Leading National Antibacterial Drugs Market Forecasts 2020-2030
12.1 Global Antibacterial Drugs Market by National Market Forecast 2020-2030
12.1.1. "V" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
12.1.2. "U" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
12.1.3. "W" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
12.1.4. "L" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
13 North America
13.1 North America Antibacterial Drugs Market by Country Forecast 2020-2030
13.2 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
13.3 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
13.4 U.S. Antibacterial Drugs Market Forecast 2020-2030
13.4.1. “V” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
13.4.2. “U” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
13.4.3. “W” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
13.4.4. “L” Shaped Recovery Scenario: U.S .Antibacterial Drugs Market Forecast 2020-2030
13.5 Canada Antibacterial Drugs Market Forecast 2020-2030
13.5.1. “V” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
13.5.2. “U” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
13.5.3. “W” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
13.5.4. “L” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
14 Europe
14.1 Europe Antibacterial Drugs Market by Country Forecast 2020-2030
14.2 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
14.3 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
14.4 Germany Antibacterial Drugs Market Forecast 2020-2030
14.4.1. “V” Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
14.4.2. “U” Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
14.4.3. “W” Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
14.4.4. “L” Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
14.5 France Antibacterial Drugs Market Forecast 2020-2030
14.5.1. “V” Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
14.5.2. “U” Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
14.5.3. “W” Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
14.5.4. “L” Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
14.6 UK Antibacterial Drugs Market Forecast 2020-2030
14.6.1. “V” Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
14.6.2. “U” Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
14.6.3. “W” Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
14.6.4. “L” Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
14.7 Italy Antibacterial Drugs Market Forecast 2020-2030
14.7.1. “V” Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
14.7.2. “U” Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
14.7.3. “W” Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
14.7.4. “L” Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
14.8 Spain Antibacterial Drugs Market Forecast 2020-2030
14.8.1. “V” Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
14.8.2. “U” Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
14.8.3. “W” Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
14.8.4. “L” Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
14.9 Russia Antibacterial Drugs Market Forecast 2020-2030
14.9.1. “V” Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
14.9.2. “U” Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
14.9.3. “W” Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
14.9.4. “L” Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
14.10 Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
14.10.1. “V” Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
14.10.2. “U” Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
14.10.3. “W” Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
14.10.4. “L” Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
15 Asia Pacific
15.1 Asia Pacific Antibacterial Drugs Market by Country Forecast 2020-2030
15.2 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
15.3 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
15.4 Japan Antibacterial Drugs Market Forecast 2020-2030
15.4.1. “V” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
15.4.2. “U” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
15.4.3. “W” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
15.4.4. “L” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
15.5 China Antibacterial Drugs Market Forecast 2020-2030
15.5.1. “V” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
15.5.2. “U” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
15.5.3. “W” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
15.5.4. “L” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
15.6 India Antibacterial Drugs Market Forecast 2020-2030
15.6.1. “V” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
15.6.2. “U” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
15.6.3. “W” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
15.6.4. “L” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
15.7 Australia Antibacterial Drugs Market Forecast 2020-2030
15.7.1. “V” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
15.7.2. “U” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
15.7.3. “W” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
15.7.4. “L” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
15.8 15.8 South Korea Antibacterial Drugs Market Forecast 2020-2030
15.8.1. “V” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
15.8.2. “U” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
15.8.3. “W” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
15.8.4. “L” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
15.9 Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
15.9.1. “V” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
15.9.2. “U” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
15.9.3. “W” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
15.9.4. “L” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
16 Latin America
16.1 Latin America Antibacterial Drugs Market by Country Forecast 2020-2030
16.2 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
16.3 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
16.4 Brazil Antibacterial Drugs Market Forecast 2020-2030
16.4.1. “V” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
16.4.2. “U” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
16.4.3. “W” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
16.4.4. “L” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
16.5 Mexico Antibacterial Drugs Market Forecast 2020-2030
16.5.1. “V” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
16.5.2. “U” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
16.5.3. “W” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
16.5.4. “L” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
16.6 Argentina Antibacterial Drugs Market Forecast 2020-2030
16.6.1. “V” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
16.6.2. “U” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
16.6.3. “W” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
16.6.4. “L” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
16.7 16.7 Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
16.7.1. “V” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
16.7.2. “U” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
16.7.3. “W” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
16.7.4. “L” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
17 Middle East and Africa
17.1 Middle East and Africa Antibacterial Drugs Market by Country Forecast 2020-2030
17.2 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
17.3 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
17.4 GCC Antibacterial Drugs Market Forecast 2020-2030
17.4.1. “V” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
17.4.2. “U” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
17.4.3. “W” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
17.4.4. “L” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
17.5 South Africa Antibacterial Drugs Market Forecast 2020-2030
17.5.1. “V” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
17.5.2. “U” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
17.5.3. “W” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
17.5.4. “L” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
17.6 Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
17.6.1. “V” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
17.6.2. “U” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
17.6.3. “W” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
17.6.4. “L” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
18 Major Companies in the Antibacterial Drugs Market
18.1 Pfizer Inc.
18.1.1. Pfizer Inc.: Company Snapshot
18.1.2. Pfizer Inc.: Company Overview
18.1.3. Pfizer Inc.: Financials
18.1.4. Pfizer Inc.: Recent Developments
18.2 Novartis AG
18.2.1. Novartis AG: Company Snapshot
18.2.2. Novartis AG: Company Overview
18.2.3. Novartis AG: Financials
18.2.4. Novartis AG: Recent Developments
18.3 Merck KGaA
18.3.1. Merck KGaA: Company Snapshot
18.3.2. Merck KGaA: Company Overview
18.3.3. Merck KGaA: Financials
18.3.4. Merck KGaA: Recent Developments
18.4 GlaxoSmithKline PLC
18.4.1. GlaxoSmithKline PLC: Company Snapshot
18.4.2. GlaxoSmithKline PLC: Company Overview
18.4.3. GlaxoSmithKline PLC: Financials
18.4.4. GlaxoSmithKline PLC: Recent Developments
18.5 BioVersys AG
18.5.1. BioVersys AG: Company Snapshot
18.5.2. BioVersys AG: Company Overview
18.5.3. BioVersys AG: Financials
18.5.4. BioVersys AG: Recent Developments
18.6 Allecra Therapeutics GmbH
18.6.1. Allecra Therapeutics GmbH: Company Snapshot
18.6.2. Allecra Therapeutics GmbH: Company Overview
18.6.3. Allecra Therapeutics GmbH: Financials
18.6.4. Allecra Therapeutics GmbH: Recent Developments
18.7 Adenium Biotech ApS
18.7.1. Adenium Biotech ApS: Company Snapshot
18.7.2. Adenium Biotech ApS: Company Overview
18.7.3. Adenium Biotech ApS: Financials
18.7.4. Adenium Biotech ApS: Recent Developments
18.8 Bayer AG
18.8.1. Bayer AG: Company Snapshot
18.8.2. Bayer AG: Company Overview
18.8.3. Bayer AG: Financials
18.8.4. Bayer AG: Recent Developments
18.9 Eli Lilly and Company
18.9.1. Eli Lilly and Company: Company Snapshot
18.9.2. Eli Lilly and Company: Company Overview
18.9.3. Eli Lilly and Company: Financials
18.9.4. Eli Lilly and Company: Recent Developments
18.10 AstraZeneca PLC
18.10.1. AstraZeneca PLC: Company Snapshot
18.10.2. AstraZeneca PLC: Company Overview
18.10.3. AstraZeneca PLC: Financials
18.10.4. AstraZeneca PLC: Recent Developments
18.11 AbbVie Inc.
18.11.1. AbbVie Inc.: Company Snapshot
18.11.2. AbbVie Inc.: Company Overview
18.11.3. AbbVie Inc.: Financials
18.11.4. AbbVie Inc.: Recent Developments
18.12 Melinta Therapeutics
18.12.1. Melinta Therapeutics: Company Snapshot
18.12.2. Melinta Therapeutics: Company Overview
18.12.3. Melinta Therapeutics: Financials
18.12.4. Melinta Therapeutics: Recent Developments
18.13 SHIONOGI Co., Ltd.
18.13.1. SHIONOGI Co., Ltd.: Company Snapshot
18.13.2. SHIONOGI Co., Ltd.: Company Overview
18.13.3. SHIONOGI Co., Ltd.: Financials
18.13.4. SHIONOGI Co., Ltd.: Recent Developments
18.14 DAIICHI SANKYO COMPANY, LIMITED.
18.14.1. DAIICHI SANKYO COMPANY, LIMITED.: Company Snapshot
18.14.2. DAIICHI SANKYO COMPANY, LIMITED.: Company Overview
18.14.3. DAIICHI SANKYO COMPANY, LIMITED.: Financials
18.14.4. DAIICHI SANKYO COMPANY, LIMITED.: Recent Developments
18.15 Johnson & Johnson Services, Inc.
18.15.1. Johnson & Johnson Services, Inc.: Company Snapshot
18.15.2. Johnson & Johnson Services, Inc.: Company Overview
18.15.3. Johnson & Johnson Services, Inc.: Financials
18.15.4. Johnson & Johnson Services, Inc.: Recent Developments
19 Conclusion and Recommendations
19.1 Market Dynamics and Funding Situation
19.2 Current Clinical Pipeline Remains Insufficient Against Priority Pathogens
19.3 Non-traditional approaches are attracting R&D interest
19.4 Pipeline Outlook Remains Bleak
19.5 Non-traditional approaches are attracting R&D interest
List of Tables
Table 1 Global Antibacterial Drugs Market Snapshot, 2020&2030 (US$ million, CAGR %)
Table 2 Global Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
Table 3 Global Antibacterial Drugs Market for Cephalosporins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 4 “V” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 5 “U” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 6 “W” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 7 “L” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 8 Global Antibacterial Drugs Market for Penicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 9 “V” Shaped Recovery: Global Antibacterial Drugs Market for Penicillin Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 10 “U” Shaped Recovery: Global Antibacterial Drugs Market for Penicillin Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 11 “W” Shaped Recovery: Global Antibacterial Drugs Market for Penicillin’s Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 12 “L” Shaped Recovery: Global Antibacterial Drugs Market for Penicillin’s Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 13 Global Antibacterial Drugs Market for Fluoroquinolones Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 14 “V” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 15 “U” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 16 “W” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 17 “L” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 18 Global Antibacterial Drugs Market for Macrolides Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 19 “V” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 20 “U” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 21 “W” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 22 “L” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 23 Global Antibacterial Drugs Market for Carbapenems Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 24 “V” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 25 “U” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 26 “W” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 27 “L” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 28 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 29 “V” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 30 “U” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 31 “W” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 32 “L” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 33 Global Antibacterial Drugs Market Forecast by Cephalosporins, By Products, 2020-2030 (US$ million, AGR %, CAGR %)
Table 34 Global Antibacterial Drugs Market for Rocephin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 35 Global Antibacterial Drugs Market for Sulperazon Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 36 Global Antibacterial Drugs Market for Ceftin/Zinnat Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 37 Global Antibacterial Drugs Market for Meiact Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 38 Global Antibacterial Drugs Market for Flomox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 39 Global Antibacterial Drugs Market for Teflaro Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 40 Global Antibacteral Drugs Market for Zeftera Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 41 Global Antibacterial Drugs Market for Ceftolozane-tazobactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 42 Global Antibacterial Drugs Market for Ceftazidime-Avibactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 43 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 44 Global Antibacterial Drugs Market Forecast by Penicillins, 2020-2030 (US$ million, AGR %, CAGR %)
Table 45 Global Antibacterial Drugs Market for Generic Amoxicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 46 Global Antibacterial Drugs Market for Augmentin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 47 Global Antibacterial Drugs Market for Zosyn/Tazocin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 48 Global Antibacterial Drugs Market for Unasyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 49 Global Antibacterial Drugs Market for Generic amoxicllin-clavulanic acid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 50 Global Antibacterial Drugs Market for Amoxil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 51 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 52 Global Antibacterial Drugs Market Forecast by Fluoroquinolones, 2020-2030 (US$ million, AGR %, CAGR %)
Table 53 Global Antibacterial Drugs Market for Avelox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 54 Global Antibacterial Drugs Market for Cravit Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 55 Global Antibacterial Drugs Market for Vigamox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 56 Global Antibacterial Drugs Market for Ciprodex Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 57 Global Antibacterial Drugs Market for Cipro/Cirpobay Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 58 Global Antibacterial Drugs Market for Geninax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 59 Global Antibacterial Drugs Market for Baxdela Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 60 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 61 Global Antibacterial Drugs Market Forecast by Macrolides, 2020-2030 (US$ million, AGR %, CAGR %)
Table 62 Global Antibacterial Drugs Market for Biaxin/Clarith Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 63 Global Antibacterial Drugs Market for Zithromax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 64 Global Antibacterial Drugs Market for Dalacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 65 Global Antibacterial Drugs Market for Dificid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 66 Global Antibacterial Drugs Market for Solithromycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 67 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 68 Global Antibacterial Drugs Market Forecast by Carbapenems, 2020-2030 (US$ million, AGR %, CAGR %)
Table 69 Global Antibacterial Drugs Market for Invanz Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 70 Global Antibacterial Drugs Market for Merrem/Meropen Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 71 Global Antibacterial Drugs Market for Primaxin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 72 Global Antibacterial Drugs Market for Doribax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 73 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 74 Global Antibacterial Drugs Market Forecast by Other Sectors, 2020-2030 (US$ million, AGR %, CAGR %)
Table 75 Global Antibacterial Drugs Market for Zyvox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 76 Global Antibacterial Drugs Market for Cubicin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 77 Global Antibacterial Drugs Market for Tygacil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 78 Global Antibacterial Drugs Market for TOBI/TIP Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 79 Global Antibacterial Drugs Market for Solodyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 80 Global Antibacterial Drugs Market for Vibativ Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 81 Global Antibacterial Drugs Market for Sirturo Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 82 Global Antibacterial Drugs Market for Tedizolid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 83 Global Antibacterial Drugs Market for Oritavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 84 Global Antibacterial Drugs Market for Dalbavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 85 Global Antibacterial Drugs Market for Nemonoxacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 86 Global Antibacterial Drugs Market for Surotomycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 87 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 88 Global Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
Table 89 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 90 “V” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 91 “U” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 92 “W” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 93 “L” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 94 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 95 “V” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 96 “U” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 97 “W” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 98 “L” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 99 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 100 “V” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 101 “U” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 102 “W” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 103 “L” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 104 Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 105 “V” Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 106 “U” Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 107 “W” Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 108 “L” Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 109 North America Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
Table 110 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
Table 111 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
Table 112 U.S .Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 113 “V” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
Table 114 “U” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
Table 115 “W” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
Table 116 “L” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
Table 117 Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 118 “V” Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
Table 119 “U” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
Table 120 “W” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
Table 121 “L” Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
Table 122 Europe Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
Table 123 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
Table 124 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
Table 125 Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 126 “V” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 127 “U” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 128 “W” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 129 “L” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 130 France Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 131 “V” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 132 “U” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 133 “W” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 134 “L” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 135 UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 136 “V” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 137 “U” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 138 “W” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 139 “L” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 140 Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 141 “V” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 142 “U” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 143 “W” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 144 “L” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 145 Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 146 “V” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 147 “U” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 148 “W” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 149 “L” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 150 Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 151 “V” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 152 “U” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 153 “W” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 154 “L” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 155 Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 156 “V” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 157 “U” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 158 “W” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 159 “L” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Table 160 Asia Pacific Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
Table 161 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
Table 162 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
Table 163 Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 164 “V” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
Table 165 “U” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
Table 166 “W” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
Table 167 “L” Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
Table 168 China Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 169 “V” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
Table 170 “U” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
Table 171 “W” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
Table 172 “L” Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
Table 173 India Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 174 “V” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
Table 175 “U” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
Table 176 “W” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
Table 177 “L” Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
Table 178 Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 179 “V” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
Table 180 “U” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
Table 181 “W” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
Table 182 “L” Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
Table 183 South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 184 “V” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
Table 185 “U” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
Table 186 “W” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
Table 187 “L” Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
Table 188 Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 189 “V” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
Table 190 “U” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
Table 191 “W” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
Table 192 “L” Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
Table 193 Latin America Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
Table 194 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
Table 195 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
Table 196 Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 197 “V” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
Table 198 “U” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
Table 199 Middle East and Africa Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
Table 200 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
Table 201 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
Table 202 GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 203 “V” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
Table 204 “U” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
Table 205 “W” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
Table 206 “L” Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
Table 207 South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 208 “V” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
Table 209 “U” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
Table 210 “W” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
Table 211 “L” Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
Table 212 Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 213 “V” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
Table 214 “U” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
Table 215 “W” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
Table 216 “L” Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
Table 217 Pfizer Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 218 Novartis AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 219 Merck KGaA: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 220 GlaxoSmithKline PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 221 BioVersys AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 222 Allecra Therapeutics GmbH: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 223 Adenium Biotech ApS: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 224 Bayer AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 225 Eli Lilly and Company: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 226 AstraZeneca PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 227 AbbVie Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 228 Melinta Therapeutics: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 229 SHIONOGI Co., Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 230 DAIICHI SANKYO COMPANY, LIMITED.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 231 Johnson & Johnson Services, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
List of Figures
Figure 1 Global Antibacterial Drugs Market Segmentation
Figure 2 U.S. approvals of anti-infectives by year
Figure 3 Porter’s Analysis
Figure 4 PEST Analysis
Figure 5 Value Chain Analysis
Figure 6 Global Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %)
Figure 7 Global Antibacterial Drugs Market Share Forecast by Type, 2020, 2025, 2030 (%)
Figure 8 Global Antibacterial Drugs Market for Cephalosporins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 9 “V” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 10 “U” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 11 “W” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 12 “L” Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 13 Global Antibacterial Drugs Market for Penicillins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 14 “V” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 15 “U” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 16 “W” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 17 “L” Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 18 Global Antibacterial Drugs Market for Fluoroquinolones Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 19 “V” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 20 “U” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 21 “W” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 22 “L” Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 23 Global Antibacterial Drugs Market for Macrolides Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 24 “V” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 25 “U” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 26 “W” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 27 “L” Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 28 Global Antibacterial Drugs Market for Carbapenems Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 29 “V” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 30 “U” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 31 “W” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 32 “L” Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 33 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 34 “V” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 35 “U” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 36 “W” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 37 “L” Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 38 Global Antibacterial Drugs Market Forecast by Cephalosporins, 2020-2030 (US$ million, AGR %)
Figure 39 Global Antibacterial Drugs Market Share Forecast by Cephalosporins, 2020, 2025, 2030 (%)
Figure 40 Global Antibacterial Drugs Market for Rocephin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 41 Global Antibacterial Drugs Market for Sulperazon Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 42 Global Antibacterial Drugs Market for Ceftin/Zinnat Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 43 Global Antibacterial Drugs Market for Meiact Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 44 Global Antibacterial Drugs Market for Flomox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 45 Global Antibacterial Drugs Market for Teflaro Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 46 Global Antibacterial Drugs Market for Zeftera Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 47 Global Antibacterial Drugs Market for Ceftolozane-tazobactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 48 Global Antibacterial Drugs Market for Ceftazidime-Avibactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 49 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 50 Global Antibacterial Drugs Market Forecast by Penicillins, 2020-2030 (US$ million, AGR %)
Figure 51 Global Antibacterial Drugs Market Share Forecast by Penicillins, 2020, 2025, 2030 (%)
Figure 52 Global Antibacterial Drugs Market for Generic Amoxicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 53 Global Antibacterial Drugs Market for Augmentin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 54 Global Antibacterial Drugs Market for Zosyn/Tazocin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 55 Global Antibacterial Drugs Market for Unasyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 56 Global Antibacterial Drugs Market for Generic amoxicllin-clavulanic acid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 57 Global Antibacterial Drugs Market for Amoxil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 58 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 59 Global Antibacterial Drugs Market Forecast by Fluoroquinolones, 2020-2030 (US$ million, AGR %)
Figure 60 Global Antibacterial Drugs Market Share Forecast by Fluoroquinolones, 2020, 2025, 2030 (%)
Figure 61 Global Antibacterial Drugs Market for Avelox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 62 Global Antibacterial Drugs Market for Cravit Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 63 Global Antibacterial Drugs Market for Vigamox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 64 Global Antibacterial Drugs Market for Ciprodex Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 65 Global Antibacterial Drugs Market for Cipro/Cirpobay Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 66 Global Antibacterial Drugs Market for Geninax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 67 Global Antibacterial Drugs Market for Baxdela Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 68 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 69 Global Antibacterial Drugs Market Forecast by Macrolides, 2020-2030 (US$ million, AGR %)
Figure 70 Global Antibacterial Drugs Market Share Forecast by Macrolides, 2020, 2025, 2030 (%)
Figure 71 Global Antibacterial Drugs Market for Biaxin/Clarith Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 72 Global Antibacterial Drugs Market for Zithromax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 73 Global Antibacterial Drugs Market for Dalacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 74 Global Antibacterial Drugs Market for Dificid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 75 Global Antibacterial Drugs Market for Solithromycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 76 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 77 Global Antibacterial Drugs Market Forecast by Carbapenems, 2020-2030 (US$ million, AGR %)
Figure 78 Global Antibacterial Drugs Market Share Forecast by Carbapenems, 2020, 2025, 2030 (%)
Figure 79 Global Antibacterial Drugs Market for Invanz Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 80 Global Antibacterial Drugs Market for Merrem/Meropen Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 81 Global Antibacterial Drugs Market for Primaxin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 82 Global Antibacterial Drugs Market for Doribax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 83 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 84 Global Antibacterial Drugs Market Forecast by Other Sectors, 2020-2030 (US$ million, AGR %)
Figure 85 Global Antibacterial Drugs Market for Zyvox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 86 Global Antibacterial Drugs Market for Cubicin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 87 Global Antibacterial Drugs Market for Tygacil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 88 Global Antibacterial Drugs Market for TOBI/TIP Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 89 Global Antibacterial Drugs Market for Solodyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 90 Global Antibacterial Drugs Market for Vibativ Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 91 Global Antibacterial Drugs Market for Sirturo Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 92 Global Antibacterial Drugs Market for Tedizolid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 93 Global Antibacterial Drugs Market for Oritavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 94 Global Antibacterial Drugs Market for Dalbavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 95 Global Antibacterial Drugs Market for Nemonoxacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 96 Global Antibacterial Drugs Market for Surotomycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 97 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 98 Global Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %)
Figure 99 Global Antibacterial Drugs Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%)
Figure 100 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 101 “V” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 102 “U” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 103 “W” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 104 “L” Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 105 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 106 “V” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 107 “U” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 108 “W” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 109 “L” Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 110 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 111 “V” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 112 “U” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 113 “W” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 114 “L” Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 115 Global Antibacterial Drugs Market Forecast by Region 2020-2030 (US$ million)
Figure 116 Global Antibacterial Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 117 North America Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
Figure 118 North America Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 119 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
Figure 120 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
Figure 121 U.S. Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 122 “V” Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 123 “U” Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 124 “W” Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 125 “L” Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 126 Canada Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 127 “V” Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 128 “U” Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 129 “W” Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 130 “L” Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 131 Europe Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
Figure 132 Europe Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 133 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
Figure 134 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
Figure 135 Germany Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 136 “V” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 137 “U” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 138 “W” Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 139 “L” Shaped Recovery: German y Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 140 France Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 141 “V” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 142 “U” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 143 “W” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 144 “L” Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 145 UK Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 146 “V” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 147 “U” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 148 “W” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 149 “L” Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 150 Italy Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 151 “V” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 152 “U” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 153 “W” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 154 “L” Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 155 Spain Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 156 “V” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 157 “U” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 158 “W” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 159 “L” Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 160 Russia Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 161 “V” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 162 “U” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 163 “W” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 164 “L” Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 165 Rest of Europe Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 166 “V” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 167 “U” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 168 “W” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 169 “L” Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 170 Asia Pacific Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
Figure 171 Asia Pacific Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 172 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
Figure 173 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
Figure 174 Japan Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 175 “V” Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 176 “U” Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 177 “W” Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 178 “L” Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 179 China Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 180 “V” Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 181 “U” Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 182 “W” Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 183 “L” Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 184 India Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 185 “V” Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 186 “U” Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 187 “W” Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 188 “L” Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 189 Australia Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 190 “V” Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 191 “U” Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 192 “W” Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 193 “L” Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 194 South Korea Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 195 “V” Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 196 “U” Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 197 “W” Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 198 “L” Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 199 Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 200 “V” Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 201 “U” Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 202 “W” Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 203 “L” Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 204 Latin America Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
Figure 205 Latin America Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 206 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
Figure 207 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
Figure 208 Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Figure 209 Brazil Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 210 “V” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
Figure 211 “V” Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 212 “U” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
Figure 213 “U” Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 214 “W” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
Figure 215 “W” Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 216 “L” Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
Figure 217 “L” Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 218 Mexico Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 219 “V” Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 220 “U” Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 221 “W” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
Figure 222
Figure 223 “W” Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 224 “L” Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
Figure 225 “L” Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 226 Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Figure 227 Argentina Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 228
Figure 229 “V” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
Figure 230 “V” Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 231
Figure 232 “U” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
Figure 233 “U” Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 234 “W” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
Figure 235 “W” Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 236 “L” Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
Figure 237 “L” Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 238 Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Figure 239 Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 240 “V” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
Figure 241
Figure 242 “V” Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 243
Figure 244 “U” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
Figure 245 “U” Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 246 “W” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
Figure 247 “W” Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 248 “L” Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
Figure 249 “L” Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 250 Middle East and Africa Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
Figure 251 Middle East and Africa Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 252 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
Figure 253 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
Figure 254 GCC Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 255 “V” Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 256 “U” Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 257 “W” Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 258 “L” Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 259 South Africa Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 260 “V” Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 261 “U” Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 262 “W” Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 263 “L” Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 264 Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
Figure 265 “V” Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 266 “U” Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 267 “W” Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 268 “L” Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 269 Pfizer Inc. : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 270 Novartis AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 271 Merck KGaA : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 272 GlaxoSmithKline PLC : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 273 BioVersys AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 274 Allecra Therapeutics GmbH : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 275 Adenium Biotech ApS : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 276 Bayer AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 277 Eli Lilly and Company : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 278 AstraZeneca PLC : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 279 Abbvie : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 280 Melinta Therapeutics : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 281 SHIONOGI Co., Ltd. : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 282 DAIICHI SANKYO COMPANY, LIMITED. : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 283 Johnson & Johnson Services, Inc. : Company Financials, 2015-2019 (US$ Mn, AGR%)
Figure 284 Antibacterial agents in clinical development (Phase 1–3) as of September 2019
Figure 285 Summary of antibiotics in the clinical pipeline targeting the WHO priority pathogens
AbbVie Inc.
Achaogen
Adenium Biotech ApS
Alaxia Pharma
Allecra Therapeutics
Allergan, Actelion
AstraZeneca PLC
Bayer AG
Biocidium Biopharmaceuticals
BioVersys AG
Bugworks
Cadila Healthcare
Cellceutix Corporation
Cempra
ContraFect
DAIICHI SANKYO COMPANY, LIMITED
DebioPharm
Dr. Reddy’s Laboratories
Eli Lilly and Company
Evotec Pharmaceuticals
EYDO Pharma
Galapagos
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Kyorin Pharmaceutical
Lupin
Macleod Pharmaceuticals
Meiji Seika Pharma
Melinta Therapeutics
Merck KGaA
MerLion Pharmaceuticals
MGB-Biopharma
MicuRx Pharmaceuticals
Nabriva Therapeutics
Nektar Therapeutics
Northern Antibiotics
Novartis AG
Ostuka
Paratek Pharmaceuticals
Pfizer Inc.
Phico Therapeutics
Redx Pharma
Savara Pharmaceuticals
SHIONOGI Co., Ltd.
Summit Therapeutics
The Medicines Company
Theravance Biopharma
Torrent Pharmaceuticals
TTY Biopharma
Unichem Laboratories
Wockhardt
Zydus Pharmaceuticals, Inc.
Organizations Mentioned in the Report
Centers for Disease Control and Prevention
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
International Society of Antimicrobial Chemotherapy
National Institute for Health and Clinical Excellence (NICE)
National Institutes of Health (NIH)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Antibacterial Drugs Market Report 2020-2030Related reports
-
Transplant Diagnostics Market Forecast 2020-2030
The increasing demand for diagnostic treatment used before the procedure is a major driver of organ transplants. Transplant production was...Full DetailsPublished: 01 January 1970 -
Antibiotic Resistance Market Report 2019-2029
Along with revenue prediction for the overall world market, there are 3 segmentations of the Antibiotic Resistance market, with forecasts...
Full DetailsPublished: 01 January 1970 -
Myeloproliferative Disorders Drugs Report 2020-2030
Myeloproliferative Disorders Drugs– our new study reveals trends, R&D progress, and predicted revenues
Where is the Myeloproliferative Disorders Drugs market...Full DetailsPublished: 01 January 1970 -
Atopic Dermatitis Drugs Market Forecast 2020-2030
The Atopic Dermatitis Drugs market is projected at USD 5.5 billion in 2020.
...Full DetailsPublished: 01 January 1970 -
Dermatological Drugs Market Forecast 2020-2030
The revenue of the dermatological drugs market in 2018 is estimated at $31bn and is expected to grow at a...Full DetailsPublished: 31 October 2019 -
Global Anti-obesity Drugs Market Forecast 2020-2030
The global anti-obesity drugs market is estimated to have reached $1.9bn in 2019 and is expected to grow at a...
Full DetailsPublished: 27 February 2020 -
Migraine Drugs Market Analysis Report 2020-2030
our new study reveals trends, R&D progress, and predicted revenues
Where is the Migraine Drugs market heading? If you are...Full DetailsPublished: 01 January 1970 -
Global Transplant Market Forecast 2019-2029
The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from...
Full DetailsPublished: 18 December 2018 -
Generic Drugs Market Report 2020-2030
Reduction in healthcare expenditure by generic medicines has been acknowledged for a long time. Multiple studies have proven that substituting...
Full DetailsPublished: 03 July 2020 -
Allergic Rhinitis Drugs Market Report 2020-2030
Our 330+ page report provides 450+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry...
Full DetailsPublished: 29 June 2020
Download sample pages
Complete the form below to download your free sample pages for Antibacterial Drugs Market Report 2020-2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
